MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$158,408K
(5.91%↑ Y/Y)
Net loss
-$158,349K
(5.96%↑ Y/Y)
Unrealized (loss) gain on
available-for-sale investments
-$59K
(-326.92%↓ Y/Y)
Income tax benefit
(expense)
-$6,162K
(-766.16%↓ Y/Y)
Loss before income
taxes
-$164,511K
(1.76%↑ Y/Y)
Interest income and
other, net
$16,376K
(-35.76%↓ Y/Y)
Loss from operations
-$180,887K
(6.25%↑ Y/Y)
Total operating
expenses
$180,887K
(-6.25%↓ Y/Y)
Research and development
$148,024K
(2.72%↑ Y/Y)
General and
administrative
$32,863K
(-32.73%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. (AVIR)